%0 Journal Article
%A García-Fortes, María
%A Hernández-Boluda, Juan C
%A Álvarez-Larrán, Alberto
%A Raya, José M
%A Angona, Anna
%A Estrada, Natalia
%A Fox, Laura
%A Cuevas, Beatriz
%A García-Hernández, María C
%A Gómez-Casares, María Teresa
%A Ferrer-Marín, Francisca
%A Saavedra, Silvana
%A Cervantes, Francisco
%A García-Delgado, Regina
%A On Behalf Of The Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas Gemfin,
%T Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis.
%D 2022
%@ 2072-6694
%U http://hdl.handle.net/10668/20891
%X The comorbidity burden is an important risk factor for overall survival (OS) in several hematological malignancies. This observational prospective study was conducted to evaluate the impact of individual comorbidities on survival in a multicenter series of 668 patients with primary myelofibrosis (PMF) or MF secondary to polycythemia vera (PPV-MF) or essential thrombocythemia (PET-MF). Hypertension (hazard ratio (HR) = 4.96, p
%K comorbidities
%K myelofibrosis
%K prognosis
%K survival
%~